BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2039550)

  • 1. Uroporphyria produced in mice by iron and 5-aminolevulinic acid.
    Deam S; Elder GH
    Biochem Pharmacol; 1991 Jun; 41(12):2019-22. PubMed ID: 2039550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid.
    Urquhart AJ; Elder GH; Roberts AG; Lambrecht RW; Sinclair PR; Bement WJ; Gorman N; Sinclair JA
    Biochem J; 1988 Jul; 253(2):357-62. PubMed ID: 3178718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uroporphyria induced by 5-aminolaevulinic acid alone in Ahrd SWR mice.
    Constantin D; Francis JE; Akhtar RA; Clothier B; Smith AG
    Biochem Pharmacol; 1996 Nov; 52(9):1407-13. PubMed ID: 8937451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation of iron-induced uroporphyria in mice.
    Smith AG; Francis JE
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):29-35. PubMed ID: 8471047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-linked hepatic uroporphyria and the induction of cytochromes P450IA in rats caused by hexachlorobenzene and polyhalogenated biphenyls.
    Smith AG; Francis JE; Green JA; Greig JB; Wolf CR; Manson MM
    Biochem Pharmacol; 1990 Nov; 40(9):2059-68. PubMed ID: 2173599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uroporphyria in the Cyp1a2-/- mouse.
    Phillips JD; Kushner JP; Bergonia HA; Franklin MR
    Blood Cells Mol Dis; 2011 Dec; 47(4):249-54. PubMed ID: 21880518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uroporphyria in mice: thresholds for hepatic CYP1A2 and iron.
    Gorman N; Ross KL; Walton HS; Bement WJ; Szakacs JG; Gerhard GS; Dalton TP; Nebert DW; Eisenstein RS; Sinclair JF; Sinclair PR
    Hepatology; 2002 Apr; 35(4):912-21. PubMed ID: 11915039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uroporphyria in Hfe mutant mice given 5-aminolevulinate: a new model of Fe-mediated porphyria cutanea tarda.
    Sinclair PR; Gorman N; Walton HS; Bement WJ; Sinclair JF; Gerhard GS; Szakacs JG; Andrews NC; Levy JE
    Hepatology; 2001 Feb; 33(2):406-12. PubMed ID: 11172342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uroporphyria caused by acetone and 5-aminolevulinic acid in iron-loaded mice.
    Sinclair PR; Bement WJ; Lambrecht RW; Jacobs JM; Sinclair JF
    Biochem Pharmacol; 1989 Dec; 38(23):4341-4. PubMed ID: 2597205
    [No Abstract]   [Full Text] [Related]  

  • 10. Polycyclic aromatic hydrocarbons cause hepatic porphyria in iron-loaded C57BL/10 mice: comparison of uroporphyrinogen decarboxylase inhibition with induction of alkoxyphenoxazone dealkylations.
    Francis JE; Smith AG
    Biochem Biophys Res Commun; 1987 Jul; 146(1):13-20. PubMed ID: 3606611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism.
    Smith AG; Francis JE; Kay SJ; Greig JB; Stewart FP
    Biochem J; 1986 Sep; 238(3):871-8. PubMed ID: 3800966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the Ah locus in hexachlorobenzene-induced porphyria. Studies in congenic C57BL/6J mice.
    Hahn ME; Gasiewicz TA; Linko P; Goldstein JA
    Biochem J; 1988 Aug; 254(1):245-54. PubMed ID: 2845946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice.
    Sinclair PR; Gorman N; Dalton T; Walton HS; Bement WJ; Sinclair JF; Smith AG; Nebert DW
    Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):149-53. PubMed ID: 9461503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells.
    Bonkovsky HL
    Hepatology; 1989 Sep; 10(3):354-64. PubMed ID: 2759551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron.
    Sinclair PR; Gorman N; Walton HS; Bement WJ; Dalton TP; Sinclair JF; Smith AG; Nebert DW
    Toxicol Appl Pharmacol; 2000 Jan; 162(1):60-7. PubMed ID: 10631128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cytochrome P450 activities by polychlorinated biphenyls in isolated mouse hepatocytes. Influence of Ah-phenotype and iron.
    Madra S; Smith AG
    Biochem Pharmacol; 1992 Aug; 44(3):455-64. PubMed ID: 1510696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute requirement for iron in the development of chemically induced uroporphyria in mice treated with 3-methylcholanthrene and 5-aminolevulinate.
    Nakano K; Ishizuka M; Sakamoto KQ; Fujita S
    Biometals; 2009 Apr; 22(2):345-51. PubMed ID: 18956144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of S-adenosyl-L-methionine in hepatic uroporphyria. Evaluation in an experimental model.
    Cantoni L; Budillon G; Cuomo R; RodinĂ² S; Le Grazie C; Di Padova C; Rizzardini M
    Scand J Gastroenterol; 1990 Oct; 25(10):1034-40. PubMed ID: 2263875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of inhibition of uroporphyrinogen decarboxylase in PCB-induced porphyria in mice.
    Seki Y; Kawanishi S; Sano S
    Toxicol Appl Pharmacol; 1987 Aug; 90(1):116-25. PubMed ID: 3114913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda.
    Elder GH; Lee GB; Tovey JA
    N Engl J Med; 1978 Aug; 299(6):274-8. PubMed ID: 661926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.